146 related articles for article (PubMed ID: 35612423)
1.
Jiang F; Shen Q; Zhang F; Fu J; Hu L; Wang J; Zhou H; Chen J; Wang Y
DNA Cell Biol; 2022 Jun; 41(6):631-640. PubMed ID: 35612423
[TBL] [Abstract][Full Text] [Related]
2. Elevated Glutathione Peroxidase 2 Expression Promotes Cisplatin Resistance in Lung Adenocarcinoma.
Du H; Chen B; Jiao NL; Liu YH; Sun SY; Zhang YW
Oxid Med Cell Longev; 2020; 2020():7370157. PubMed ID: 32215178
[TBL] [Abstract][Full Text] [Related]
3. PRDM14 mediates chemosensitivity and glycolysis in drug‑resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells.
He S; Ma X; Zheng N; Wang G; Wang M; Xia W; Yu D
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355367
[TBL] [Abstract][Full Text] [Related]
4. Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway.
Danni X; Jiangzheng Z; Huamao S; Yinglian P; Changcheng Y; Yanda L
Bioengineered; 2021 Dec; 12(1):7335-7347. PubMed ID: 34612768
[TBL] [Abstract][Full Text] [Related]
5. miR-125b reverses cisplatin resistance by regulating autophagy via targeting RORA/BNIP3L axis in lung adenocarcinoma.
Liu L; Guo NA; Li X; Xu Q; He R; Cheng L; Dang C; Bai X; Bai Y; Wang X; Chen Q; Zhang LI
Oncol Res; 2024; 32(4):643-658. PubMed ID: 38560570
[TBL] [Abstract][Full Text] [Related]
6. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.
Du H; Li Y; Sun R; Yuan Y; Sun S; Zhang Y
Thorac Cancer; 2020 Sep; 11(9):2473-2482. PubMed ID: 32648688
[TBL] [Abstract][Full Text] [Related]
7. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
[TBL] [Abstract][Full Text] [Related]
8. miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549.
Deng SH; Wu DM; Li L; Liu T; Zhang T; Li J; Yu Y; He M; Zhao YY; Han R; Xu Y
Biochem Biophys Res Commun; 2021 Apr; 549():54-60. PubMed ID: 33662669
[TBL] [Abstract][Full Text] [Related]
9. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
Mao Y; Xu R
Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
[TBL] [Abstract][Full Text] [Related]
10. An inverse interaction between
Zhang Y; Yuan Y; Li Y; Zhang P; Chen P; Sun S
Epigenetics; 2019 Oct; 14(10):949-960. PubMed ID: 31144606
[No Abstract] [Full Text] [Related]
11. Elevated TRIM23 expression predicts cisplatin resistance in lung adenocarcinoma.
Zhang Y; Du H; Li Y; Yuan Y; Chen B; Sun S
Cancer Sci; 2020 Feb; 111(2):637-646. PubMed ID: 31677335
[TBL] [Abstract][Full Text] [Related]
12. CPSF6-mediated XBP1 3'UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma.
Zhu C; Xie Y; Li Q; Zhang Z; Chen J; Zhang K; Xia X; Yu D; Chen D; Yu Z; Chen J
Drug Resist Updat; 2023 May; 68():100933. PubMed ID: 36821972
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional factor MAZ promotes cisplatin-induced DNA damage repair in lung adenocarcinoma by regulating NEIL3.
Wang T; Zhu X; Wang K; Li J; Hu X; Lin P; Zhang J
Pulm Pharmacol Ther; 2023 Jun; 80():102217. PubMed ID: 37121465
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA11-AS drives cisplatin resistance of human LUAD cells via modulating miR-454-3p/Stat3.
Zhao X; Li X; Zhou L; Ni J; Yan W; Ma R; Wu J; Feng J; Chen P
Cancer Sci; 2018 Oct; 109(10):3068-3079. PubMed ID: 30099826
[TBL] [Abstract][Full Text] [Related]
15. MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray data.
Lu M; Hu C; Wu F; Shu L; Pan Y; Liu X; Liu P; Ma F; Deng C; Huang M
Lung Cancer; 2020 Sep; 147():193-197. PubMed ID: 32731058
[TBL] [Abstract][Full Text] [Related]
16. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.
Shi W; Ling L; Li C; Wu R; Zhang M; Shao F; Wang Y
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1295-1311. PubMed ID: 35792913
[TBL] [Abstract][Full Text] [Related]
17. Ring finger protein 6 enhances chemo-resistance by transcriptionally activating proliferating cell nuclear antigen expression and attenuating DNA damage in lung adenocarcinoma.
Sun Y; Sun H; Qi Y; Pan M; An N; Leng X; Liu Y; Chen Z
Cancer Lett; 2022 May; 534():215609. PubMed ID: 35278611
[TBL] [Abstract][Full Text] [Related]
18. CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma.
He J; Lan X; Liu X; Deng C; Luo H; Wang Y; Kang P; Sun Z; Zhao L; Zhou X
BMC Cancer; 2023 Mar; 23(1):266. PubMed ID: 36959566
[TBL] [Abstract][Full Text] [Related]
19. SNHG15 enhances cisplatin resistance in lung adenocarcinoma by affecting the DNA repair capacity of cancer cells.
Li Y; Huang HQ; Huang ZH; Yu ND; Ye XL; Jiang MC; Chen LM
Diagn Pathol; 2023 Mar; 18(1):33. PubMed ID: 36864456
[TBL] [Abstract][Full Text] [Related]
20. CircPVT1 contributes to chemotherapy resistance of lung adenocarcinoma through miR-145-5p/ABCC1 axis.
Zheng F; Xu R
Biomed Pharmacother; 2020 Apr; 124():109828. PubMed ID: 31986409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]